{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:08:49Z","timestamp":1791925729088,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005626","name":"University of Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005626","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.psyneuen.2013.03.003","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T04:32:28Z","timestamp":1365481948000},"page":"1985-1993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":465,"title":["Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice"],"prefix":"10.1016","volume":"38","author":[{"given":"Inga D.","family":"Neumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigue","family":"Maloumby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela I.","family":"Beiderbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Landgraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2013.03.003_bib0005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neulet.2003.12.005","article-title":"Intranasal administration of nap, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze","volume":"361","author":"Alcalay","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0010","first-page":"301","article-title":"Social effects of oxytocin in humans: context and person matter","volume":"15","author":"Bartz","year":"2011","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.npp.1301193","article-title":"Intranasal insulin improves memory in humans: superiority of insulin aspart","volume":"32","author":"Benedict","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0020","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/j.1471-4159.1989.tb07243.x","article-title":"Brain microdialysis","volume":"52","author":"Benveniste","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0025","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0030","doi-asserted-by":"crossref","first-page":"e27237","DOI":"10.1371\/journal.pone.0027237","article-title":"Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats","volume":"6","author":"Bowen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0079-6123(08)60063-1","article-title":"Extrahypothalamic vasopressin and oxytocin innervation of fetal and adult rat brain","volume":"53","author":"Buijs","year":"1980","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-1998-1102","article-title":"Delivery of nerve growth factor to the brain via the olfactory pathway","volume":"1","author":"Chen","year":"1998","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/hbeh.1999.1558","article-title":"Peripheral pulses of oxytocin increase partner preferences in female, but not male, prairie voles","volume":"37","author":"Cushing","year":"2000","journal-title":"Horm. Behav."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0050","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0055","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/jps.21604","article-title":"Intranasal drug targeting of hypocretin-1 (orexin-a) to the central nervous system","volume":"98","author":"Dhuria","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0060","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.biopsych.2010.04.039","article-title":"Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients","volume":"68","author":"Feifel","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0065","first-page":"46","article-title":"Bypassing the blood\u2013brain barrier to delivery therapeutic agents to the brain and spinal cord","volume":"5","author":"Frey","year":"2002","journal-title":"Drug Deliv. Technol."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0070","doi-asserted-by":"crossref","first-page":"9400","DOI":"10.1073\/pnas.1000985107","article-title":"Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans","volume":"107","author":"Gamer","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.npep.2012.07.001","article-title":"Oxytocin plasma concentrations after single intranasal oxytocin administration \u2013 a study in healthy men","volume":"46","author":"Gossen","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1073\/pnas.93.1.427","article-title":"Neuroprotective strategy for alzheimer disease: Intranasal administration of a fatty neuropeptide","volume":"93","author":"Gozes","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0085","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.psyneuen.2009.05.017","article-title":"Oxytocin protects against negative behavioral and autonomic consequences of long-term social isolation","volume":"34","author":"Grippo","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0090","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biopsych.2009.09.020","article-title":"Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders","volume":"67","author":"Guastella","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0095","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-9-S3-S5","article-title":"Intranasal delivery bypasses the blood\u2013brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9","author":"Hanson","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0100","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.biopsych.2006.05.030","article-title":"Oxytocin increases retention of social cognition in autism","volume":"61","author":"Hollander","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.npp.1300021","article-title":"Oxytocin infusion reduces repetitive behaviors in adults with autistic and asperger's disorders","volume":"28","author":"Hollander","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0110","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.physbeh.2005.01.007","article-title":"Oxytocin is not a valid biomarker when measured in saliva by immunoassay","volume":"84","author":"Horvat-Gordon","year":"2005","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0115","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/npp.2011.317","article-title":"Intranasally administered neuropeptide s (nps) exerts anxiolytic effects following internalization into nps receptor-expressing neurons","volume":"37","author":"Ionescu","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0120","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0002-9378(12)90854-6","article-title":"Oxytocin modulates oxytocin neurons in the paraventricular nuclei of female rats throughout pregnancy and parturition","volume":"168","author":"Kawarabayashi","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0125","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1523\/JNEUROSCI.3984-05.2005","article-title":"Oxytocin modulates neural circuitry for social cognition and fear in humans","volume":"25","author":"Kirsch","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0130","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.neuron.2011.11.030","article-title":"Evoked axonal oxytocin release in the central amygdala attenuates fear response","volume":"73","author":"Knobloch","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0135","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/npp.2010.123","article-title":"Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder","volume":"35","author":"Labuschagne","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0029-1210444","article-title":"Plasma oxytocin concentrations in man after different routes of administration of synthetic oxytocin","volume":"85","author":"Landgraf","year":"1985","journal-title":"Exp. Clin. Endocrinol."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0145","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.yfrne.2004.05.001","article-title":"Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication","volume":"25","author":"Landgraf","year":"2004","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0150","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.psyneuen.2012.01.011","article-title":"Oxytocin increases amygdala reactivity to threatening scenes in females","volume":"37","author":"Lischke","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0155","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuropharm.2011.08.016","article-title":"Nasal application of neuropeptide s reduces anxiety and prolongs memory in rats: social versus non-social effects","volume":"62","author":"Lukas","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0160","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1523\/JNEUROSCI.1350-09.2009","article-title":"Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors","volume":"29","author":"Marks","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1385\/JMN\/31:02:165","article-title":"Intranasal nap administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of alzheimer's disease at early pathological stage","volume":"31","author":"Matsuoka","year":"2007","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0006-8993(83)90478-X","article-title":"Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (csf): half-times of disappearance of these neuropeptides from csf","volume":"262","author":"Mens","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0175","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrn3044","article-title":"Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine","volume":"12","author":"Meyer-Lindenberg","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0180","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nn.3083","article-title":"Neural mechanisms of social risk for psychiatric disorders","volume":"15","author":"Meyer-Lindenberg","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0185","doi-asserted-by":"crossref","DOI":"10.1677\/joe.0.1020063","article-title":"Release of oxytocin and vasopressin by magnocellular nuclei in vitro: specific facilitatory effect of oxytocin on its own release","volume":"102","author":"Moos","year":"1984","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/endo.134.1.8275928","article-title":"An oxytocin receptor antagonist infused into the supraoptic nucleus attenuates intranuclear and peripheral release of oxytocin during suckling in conscious rats","volume":"134","author":"Neumann","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0195","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tins.2012.08.004","article-title":"Balance of brain oxytocin and vasopressin: Implications for anxiety, depression, and social behaviors","volume":"35","author":"Neumann","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0200","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0306-4530(98)00023-7","article-title":"Increased basal activity of the hypothalamo-pituitary-adrenal axis during pregnancy in rats bred for high anxiety-related behaviour","volume":"23","author":"Neumann","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0205","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1124\/jpet.107.132381","article-title":"Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins","volume":"325","author":"Nonaka","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0210","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3109\/10253890.2012.655348","article-title":"Comparison of corticosterone responses to acute stressors: chronic jugular vein versus trunk blood samples in mice","volume":"15","author":"Nyuyki","year":"2012","journal-title":"Stress"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0215","series-title":"The mouse brain in stereotaxic coordinates","author":"Paxinos","year":"1997"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0220","series-title":"The brain in stereotaxic coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0225","doi-asserted-by":"crossref","DOI":"10.1096\/fj.10-180133","article-title":"Neuropeptide pituitary adenylate cyclase-activating polypeptide (pacap) slows down alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice","author":"Rat","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0230","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates beta-amyloid in early ad","volume":"70","author":"Reger","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0235","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.biopsych.2009.06.009","article-title":"Intranasal administration of oxytocin increases envy and schadenfreude (gloating)","volume":"66","author":"Shamay-Tsoory","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0240","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuropharm.2009.06.038","article-title":"Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred wistar rats","volume":"58","author":"Slattery","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0245","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.yfrne.2011.07.001","article-title":"Prosocial effects of oxytocin and clinical evidence for its therapeutic potential","volume":"32","author":"Striepens","year":"2011","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0250","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0306-4530(02)00133-6","article-title":"The effects of vasopressin on human facial responses related to social communication","volume":"29","author":"Thompson","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0255","first-page":"1","article-title":"Neuropeptide s alters anxiety, but not depression-like behaviour in flinders sensitive line rats: a genetic animal model of depression","author":"Wegener","year":"2011","journal-title":"Int. J. Neuropsychopharmacol. FirstView"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0260","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.psyneuen.2012.02.014","article-title":"Intranasal oxytocin administration is reflected in human saliva","volume":"37","author":"Weisman","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0265","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.neuron.2004.08.005","article-title":"Neuropeptide s: a neuropeptide promoting arousal and anxiolytic-like effects","volume":"43","author":"Xu","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.psyneuen.2013.03.003_bib0270","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1523\/JNEUROSCI.4899-09.2010","article-title":"Vasopressin modulates medial prefrontal cortex-amygdala circuitry during emotion processing in humans","volume":"30","author":"Zink","year":"2010","journal-title":"J. Neurosci."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453013000772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453013000772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:42:36Z","timestamp":1759682556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453013000772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0306453013000772"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2013.03.003","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2013.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}